IceCure Medical updates proxy statement for September shareholder meeting

Published 01/08/2025, 22:46
© IceCure Medical PR

IceCure Medical (TASE:BLWV) Ltd. (NASDAQ:ICCM) filed an amendment to its previously published proxy materials for its upcoming Special General Meeting of Shareholders, according to a press release statement based on a filing with the U.S. Securities and Exchange Commission.

The amendment, submitted Friday, replaces the original Notice of Meeting and Proxy Statement that were furnished on Monday, July 28. The sole change in the updated documents is the inclusion of the website address that shareholders will use to attend the meeting remotely. No other modifications were made to the content of the proxy materials, and Exhibit 99.3, the Proxy Card, remains unchanged.

The Special General Meeting is scheduled to be held on Monday, September 1, 2025, and will take place exclusively by remote communication. Only shareholders of record holding ordinary shares at the close of business on Monday, August 4, 2025, will be entitled to receive notice of and vote at the meeting, as well as at any postponements or adjournments.

IceCure Medical Ltd. is a medical device company incorporated outside the United States, with principal executive offices in Caesarea, Israel. The information in this article is based on the company’s press release statement and SEC filing.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.